Vimarsana
Biggest News Aggregation in the World

Michael Davin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Davin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Davin Today - Breaking & Trending Today

Allurion goes public on NYSE through SPAC merger - Vimarsana News

Allurion goes public on NYSE through SPAC merger

Allurion Technologies announced that it completed a SPAC merger and began trading on the New York Stock Exchange.

eMagin Corporation (AMEX:EMAN) Q1 2023 Earnings Call Transcript - Vimarsana News

eMagin Corporation (AMEX:EMAN) Q1 2023 Earnings Call Transcript

Operator: Good morning, and welcome to the eMagin Corporation's First Quarter 2023 Earnings Conference Call. Please note, this event is being recorded.

PureTech Announces Annual Results for Year Ended December 31, 2021 - Vimarsana News

PureTech Announces Annual Results for Year Ended December 31, 2021

PureTech Announces Annual Results for Year Ended December 31, 2021 - read this article along with other careers information, tips and advice on BioSpace

Investegate |PureTech Health PLC Announcements | PureTech Health PLC: PRTC Provides Recap Ahead of Catalyst-Rich 2022 - Vimarsana News

Investegate |PureTech Health PLC Announcements | PureTech Health PLC: PRTC Provides Recap Ahead of Catalyst-Rich 2022

Investegate announcements from PureTech Health PLC, PRTC Provides Recap Ahead of Catalyst-Rich 2022

PureTech Announces Annual Results for Year Ended December 31, 2020 - Vimarsana News

PureTech Announces Annual Results for Year Ended December 31, 2020

PureTech Announces Annual Results for Year Ended December 31, 2020 By Staff 2 seconds ago Strong capital base and cash runway extended into the first quarter of 2025, with PureTech level cash and cash equivalents of $443.4 million as of March 31, 2021 1 ($349.4 million as of December 31, 2020 2) and consolidated cash and cash equivalents of $486.5 million as of March 31, 2021 3 ($403.9 million as of December 31, 2020 4) Advancement of Wholly Owned Pipeline with four clinical trial initiations and one successful readout, with three clinical trials ongoing Significant milestones across PureT...